Abstract
The growth of advanced prostate cancer depends on androgen receptor signalling, however treatment options are limited. Here we report the disruption of specific protein-protein interactions involving LXXLL motifs in androgen receptor-coregulator proteins such as PELP1 using a novel, small molecule peptidomimetic (D2). D2 is stable, non-toxic and efficiently taken up by prostate cancer cells. Importantly, D2 blocks androgen-induced nuclear uptake and genomic activity of the androgen receptor. Furthermore, D2 abrogates androgen-induced proliferation of prostate cancer cells in vitro with an IC50 of 40 nM, and inhibits tumour growth in a mouse xenograft model. D2 also disrupts androgen receptor-coregulator interactions in ex vivo cultures of primary human prostate tumours. These findings provide evidence that targeting androgen receptor-coregulator interactions using peptidomimetics may be a viable therapeutic approach for patients with advanced prostate cancer.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Motifs
-
Animals
-
Cell Line, Tumor
-
Cell Nucleus / drug effects
-
Cell Nucleus / metabolism
-
Cell Proliferation / drug effects
-
Co-Repressor Proteins / metabolism*
-
Humans
-
Male
-
Mice
-
Microscopy, Fluorescence
-
Models, Molecular
-
Peptidomimetics / chemical synthesis
-
Peptidomimetics / chemistry
-
Peptidomimetics / pharmacology*
-
Prostatectomy
-
Prostatic Neoplasms / metabolism*
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / surgery
-
Protein Binding / drug effects
-
Protein Structure, Tertiary
-
Protein Transport / drug effects
-
Receptors, Androgen / chemistry
-
Receptors, Androgen / metabolism*
-
Transcription Factors / metabolism*
-
Transcription, Genetic / drug effects
-
Xenograft Model Antitumor Assays
Substances
-
AR protein, human
-
Co-Repressor Proteins
-
PELP1 protein, human
-
Peptidomimetics
-
Receptors, Androgen
-
Transcription Factors
Associated data
-
PubChem-Substance/162169954
-
PubChem-Substance/162169955
-
PubChem-Substance/162169956
-
PubChem-Substance/162169957
-
PubChem-Substance/162169958
-
PubChem-Substance/162169959
-
PubChem-Substance/162169960
-
PubChem-Substance/162169961
-
PubChem-Substance/162169962
-
PubChem-Substance/162169963
-
PubChem-Substance/162169964
-
PubChem-Substance/162169965
-
PubChem-Substance/162169966